Drug name: Dihydralazine Sulphate
Dosage form: API
Specification: 25kg / barrel
Registration No.: Y20190004585
CDE status: A
Purpose: for the treatment of hypertension or heart failure
CAS:7327-87-9
Molecular formula: C8H12N6O4S